CDT Equity Inc. Common Stock (CDT)
Stock · NASDAQ · Health Care
$0.224as of 10/16/2026
Price chart
Active signals
CDT Signal Track Record
How signals performed across all stocks →What CDT's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 21 | -35.1% | 10% | August 25, 2026 |
| Bollinger Band Breakout | 11 | -0.4% | 45% | September 29, 2026 |
| Volume Spike | 9 | -42.3% | 11% | September 18, 2026 |
| Any 20-session window (baseline) | -23.6% | 24% |
Computed by MarketWall from daily closing prices since January 11, 2023. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About CDT
CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diab…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 4
- Website
- www.cdtequity.com/
Fundamentals
- 1-day range
- $0.1922$0.24
- Market cap
- $2.54M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-5400.37
- Dividend yield
- —
- Beta
- 1.59
- Avg. volume
- 783.1K
CDT Equity Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- CDTCDT Equity Inc. Common Stock$0.235▲ 12.44%Market cap $2.54MP/E —$0.1813$28,125
- ARTLArtelo Biosciences Inc. Common Stock$2.7▼ 1.46%Market cap $2.62MP/E —$2.92$179.19
- OGENOragenics Inc. Common Stock$0.43▼ 2.27%Market cap $2.45MP/E 0.56$0.43$1.45
- DCOYDecoy Therapeutics Inc. Common Stock$1.17▼ 4.88%Market cap $2.40MP/E —$2.01$55.92
- GRIGRI Bio Inc. Common Stock$1.38▼ 1.43%Market cap $2.74MP/E 0.04$1.36$64.12
- PPBTPurple Biotech Ltd. American Depositary Shares$1.14▼ 7.32%Market cap $2.29MP/E —$1$2.2
- SHPHShuttle Pharmaceuticals Holdings Inc. Common Stock$5.08▼ 8.80%Market cap $2.79MP/E 43.60$2.58$55.9
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CDT CDT Equity Inc. Common Stock | $2.54M | — | $0.235 | ▲ 12.44% | $0.1813$28,125 |
| ARTL Artelo Biosciences Inc. Common Stock | $2.62M | — | $2.7 | ▼ 1.46% | $2.92$179.19 |
| OGEN Oragenics Inc. Common Stock | $2.45M | 0.56 | $0.43 | ▼ 2.27% | $0.43$1.45 |
| DCOY Decoy Therapeutics Inc. Common Stock | $2.40M | — | $1.17 | ▼ 4.88% | $2.01$55.92 |
| GRI GRI Bio Inc. Common Stock | $2.74M | 0.04 | $1.38 | ▼ 1.43% | $1.36$64.12 |
| PPBT Purple Biotech Ltd. American Depositary Shares | $2.29M | — | $1.14 | ▼ 7.32% | $1$2.2 |
| SHPH Shuttle Pharmaceuticals Holdings Inc. Common Stock | $2.79M | 43.60 | $5.08 | ▼ 8.80% | $2.58$55.9 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- CDT Equity Announces Patent Filing From Sarborg Limited For Its Intellectual Property Covering Novel Solid Forms Of Respiratory Medicinebenzinga · 10/14/2026
- Friday's session: top gainers and losersChartMill · 10/2/2026
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga · 10/2/2026
- CDT Highlights Sarborg’s Expanding Quantum Computing IP Portfolio and Application to Drug DiscoveryYahoo · 9/29/2026
- Top movers in Friday's sessionChartMill · 9/25/2026
- Top movers analysis in the middle of the day on 2026-09-25: top gainers and losers in today's session.ChartMill · 9/25/2026
- Gapping stocks in Friday's sessionChartMill · 9/25/2026
- Stay updated with the stocks that are on the move in today's pre-market session.ChartMill · 9/25/2026
- CDT Equity Inc. Announces Reverse Stock SplitYahoo · 9/25/2026
Insider Activity
Insider Actions →- Regan Andrew · August 28, 2026 · X5.44M @ $0.0001
- Regan Andrew · August 28, 2026 · Sale290
- Regan Andrew · August 28, 2026 · J5.44M
- Regan Andrew · July 30, 2026 · J5.44M @ $0.0001
- Taylor Mark Andrew · June 18, 2026 · Sale593.3K @ $1.4
- Taylor Mark Andrew · June 18, 2026 · Sale5.0K @ $0.7052
- Taylor Mark Andrew · June 18, 2026 · Sale1.46M @ $1.44
- Regan Andrew · May 13, 2026 · Grant100.0K @ $1.9
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
CDT Highlights Sarborg Quantum Computing IP for Drug Discovery
CDT announced that it is focusing on Sarborg's expanding quantum computing intellectual property and its application to drug discovery. The company was also mentioned among health‑care stocks that moved in Friday's session, showing recent market attention. The stock is currently near a long‑standing support level, which may be observed as the company pursues these initiatives.
CDT Highlights Sarborg Quantum Computing IP for Drug Discovery. CDT announced that it is focusing on Sarborg's expanding quantum computing intellectual property and its application to drug discovery. The company was also mentioned among health‑care stocks that moved in Friday's session, showing recent market attention. The stock is currently near a long‑standing support level, which may be observed as the company pursues these initiatives.